Sharon A. Savage
Sharon A. Savage is a renowned oncologist and geneticist who has made significant contributions to the field of medicine. She is best known for her research on Li-Fraumeni Syndrome (LFS), a rare, inherited disorder that greatly increases the risk of developing several types of cancer, particularly in children and young adults.
Early Life and Education[edit | edit source]
Sharon A. Savage was born and raised in United States. She completed her undergraduate studies in biology at the University of Virginia, and later earned her medical degree from the University of Maryland School of Medicine. She completed her residency in Internal Medicine at the University of North Carolina Hospitals, and her fellowship in Medical Genetics at the National Institutes of Health (NIH).
Career[edit | edit source]
Savage joined the National Cancer Institute (NCI) in 2004, where she currently serves as the Chief of the Clinical Genetics Branch. Her research primarily focuses on understanding the genetic and environmental factors that contribute to the development of cancer, particularly in individuals with LFS.
Savage and her team have made several groundbreaking discoveries in the field of cancer genetics. They were the first to identify that individuals with LFS have an increased risk of developing adrenocortical carcinoma, a rare type of cancer that affects the adrenal glands. They also discovered that these individuals have a higher risk of developing early-onset breast cancer.
Contributions to Medicine[edit | edit source]
Savage's research has significantly advanced our understanding of LFS and other hereditary cancer syndromes. Her work has led to the development of new diagnostic criteria for LFS, which has improved the ability to identify individuals at risk of developing cancer. This has ultimately led to earlier detection and treatment of cancer in these individuals.
Awards and Recognition[edit | edit source]
In recognition of her contributions to the field of medicine, Savage has received numerous awards and honors. These include the NIH Director's Award for her research on LFS, and the American Society of Clinical Oncology's Young Investigator Award.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
